TiGenix awarded European Union grant
Leuven, 10 June 2008 - TiGenix (EURONEXT: TIG) announced today that it has been awarded a € 1.2 million grant from the European Union for its participation in TREAT-OA, a research consortium focused on the development of novel diagnostics and treatments for osteoarthritis.
More info on TiGenix' website or on the press release.
Next > Ensartech secures strategic investment to rollout new waste to energy conversion technology Previous > Capricorn Venture Partners closes its Cleantech Fund at € 100 million |
